Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-100866
Filing Date
2022-09-16
Accepted
2022-09-16 16:40:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2225310d2_defa14a.htm DEFA14A 21763
2 GRAPHIC tm2225310d2_defa14a-img001.jpg GRAPHIC 14960
  Complete submission text file 0001104659-22-100866.txt   43710
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 221248542
SIC: 2834 Pharmaceutical Preparations